CARBOPLATIN, PACLITAXEL, DOCETAXEL, VINORELBINE TARTRATE, CISPLATIN, PEMETREXED
EC-120888
Approved small_molecule active
Quick answer
CARBOPLATIN, PACLITAXEL, DOCETAXEL, VINORELBINE TARTRATE, CISPLATIN, PEMETREXED for Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC) is a Approved program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active